Lecture 4- principles of drug individualizing Flashcards

Drug metabolism

1
Q

Define Gene

A

segment of DNA that contains information for encoding a protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define SNPs

A

single nucleotide polymorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define alleles

A

different DNA sequences at a locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define genotypes

A

pair of alleles at a particular locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define phenotypes

A

the observable property of an organism; a trait such as height, weight, medical condition, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define Haplotype

A

a set of DNA variations, or polymorphisms, that tend to be inherited together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MDR1

A

for digosin (reduce dose if have MDR1 because have higher drug plasma level)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

3 factors affecting patient drug response

A
  1. Environment: diet, lifestyle, socioeconomics, others
  2. Biology: age, sex, others
  3. Genetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EM

A

normal metabolism (homozygous for the 2 “normal” alleles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PM

A

poor metabolizer (homozygous w/two variant alleles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IM

A

intermediate metabolizer (heterozygous)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

UM

A

ultra-rapid metabolizer (gene duplication/multiplication)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

systemic approach to genetic variations

A

identify genetic variation
determine who is impacted
identify how relevant to drug
determine how relevant to disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

goals of pharmacogenomics

A

4 rights
To Enhance drug efficacy and Reduce drug toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Initial Dose

A

based on medical need and factors that will alter the PK or PD of drug (i.e. warfarin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phase I

A

oxidation
hydroxylation
reduction
hydrolysis

(P450 CYPs)

17
Q

Phase II

A

conjugation:
- glucuronidation
- acetylation
- methylation
- glutathione conjugation
- sulphation

18
Q

Maintenance Dose

A

adjust the maintenance dose by X% up or down based on INR: caution about factors that will alter the PK and PD of drug (i.e. warfarin)

19
Q

Warfarin mechanism

A

Warfarin blocks VKOR enzyme that reduces Vit. K in order to coagulate.. therefore working as an anticoagulant

20
Q

Irinotecan

A

UGT1A1*28
neutropenia (reduce neutrophil count?)

21
Q

Codeine (prodrug for morphine)

A

CYP2D6 enzyme to activate it to morphine, but not actually morphine so no analgesic
PM: No analgesic effect
UM: respiratory depression

22
Q

Clopidogrel (prodrug)

A

if CYP2C19 low then..
PM: No drug activity cause not activated